Blue Jet Healthcare Stock Price

BLUEJET Community Fair Values

• AN

  

  AnalystConsensusTarget

  Consensus Narrative from 6 Analysts

  Advanced Manufacturing And Diversified Sourcing Will Secure Future Stability

  Key Takeaways Expansion into high-margin specialties and backward integration enhances Blue Jet's cost efficiency, product portfolio, and margin stability. Strong global pharma trends and long-term client relationships support robust, sustained demand and recurring earnings growth.

  ₹931.67

  FV

  14.5% undervalued intrinsic discount

  18.78%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  5users have followed this narrative

  3 days ago author updated this narrative
• AN

  

  AnalystHighTarget

  Consensus Narrative from 6 Analysts

  Aging Populations And Chronic Disease Will Feed Indian Pharma Outsourcing

  Key Takeaways Large-scale capacity expansion, supply chain independence, and innovative R&D position Blue Jet for significant margin and revenue growth beyond current market expectations. Strategic investments and a strong pipeline in high-demand segments give Blue Jet a defensible edge and upside from long-term demand and global supply shifts.

  ₹1.20k

  FV

  33.6% undervalued intrinsic discount

  23.23%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  0users have followed this narrative

  10 days ago author updated this narrative
• AN

  

  AnalystLowTarget

  Consensus Narrative from 6 Analysts

  Escalating Regulatory And Supply Risks Will Weaken Outlook

  Key Takeaways Margin and earnings growth are threatened by global regulatory pressures, environmental compliance costs, and increased supply chain risks linked to emerging market dependencies. Heavy reliance on a concentrated customer base and lagging technological adaptation heighten the risk of revenue volatility and competitive disadvantages.

  ₹730.00

  FV

  9.1% overvalued intrinsic discount

  13.33%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  0users have followed this narrative

  10 days ago author updated this narrative